Skip to main content
Top
Published in: BMC Musculoskeletal Disorders 1/2010

Open Access 01-12-2010 | Research article

Diagnostic reliability of magnetic resonance imaging for central nervous system syndromes in systemic lupus erythematosus: a prospective cohort study

Authors: Yasuhiro Katsumata, Masayoshi Harigai, Yasushi Kawaguchi, Chikako Fukasawa, Makoto Soejima, Tokiko Kanno, Katsuji Nishimura, Takayuki Yamada, Hisashi Yamanaka, Masako Hara

Published in: BMC Musculoskeletal Disorders | Issue 1/2010

Login to get access

Abstract

Background

Previous studies of magnetic resonance imaging (MRI) as a diagnostic tool for central nervous system (CNS) syndromes in systemic lupus erythematosus (SLE) contained several limitations such as study design, number of enrolled patients, and definition of CNS syndromes. We overcame these problems and statistically evaluated the diagnostic values of abnormal MRI signals and their chronological changes in CNS syndromes of SLE.

Methods

We prospectively studied 191 patients with SLE, comparing those with (n = 57) and without (n = 134) CNS syndrome. CNS syndromes were characterized using the American College of Rheumatology case definitions.

Results

Any abnormal MRI signals were more frequently observed in subjects in the CNS group (n = 25) than in the non-CNS group (n = 32) [relative risk (RR), 1.7; 95% confidence interval (CI), 1.1-2.7; p = 0.016] and the positive and negative predictive values for the diagnosis of CNS syndrome were 42% and 76%, respectively. Large abnormal MRI signals (ø ≥ 10 mm) were seen only in the CNS group (n = 7; RR, 3.7; CI, 2.9-4.7; p = 0.0002), whereas small abnormal MRI signals (ø < 10 mm) were seen in both groups with no statistical difference. Large signals always paralleled clinical outcome (p = 0.029), whereas small signals did not (p = 1.000).

Conclusions

Abnormal MRI signals, which showed statistical associations with CNS syndrome, had insufficient diagnostic values. A large MRI signal was, however, useful as a diagnostic and surrogate marker for CNS syndrome of SLE, although it was less common.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hanly JG, Harrison MJ: Management of neuropsychiatric lupus. Best Pract Res Clin Rheumatol. 2005, 19 (5): 799-821. 10.1016/j.berh.2005.04.003.CrossRefPubMed Hanly JG, Harrison MJ: Management of neuropsychiatric lupus. Best Pract Res Clin Rheumatol. 2005, 19 (5): 799-821. 10.1016/j.berh.2005.04.003.CrossRefPubMed
2.
go back to reference The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 1999, 42 (4): 599-608. 10.1002/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 1999, 42 (4): 599-608. 10.1002/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F.
3.
go back to reference Nishimura K, Harigai M, Omori M, Sato E, Hara M: Blood-brain barrier damage as a risk factor for corticosteroid-induced psychiatric disorders in systemic lupus erythematosus. Psychoneuroendocrinology. 2008, 33 (3): 395-403. 10.1016/j.psyneuen.2007.12.007.CrossRefPubMed Nishimura K, Harigai M, Omori M, Sato E, Hara M: Blood-brain barrier damage as a risk factor for corticosteroid-induced psychiatric disorders in systemic lupus erythematosus. Psychoneuroendocrinology. 2008, 33 (3): 395-403. 10.1016/j.psyneuen.2007.12.007.CrossRefPubMed
4.
go back to reference Sibbitt WL, Sibbitt RR, Brooks WM: Neuroimaging in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum. 1999, 42 (10): 2026-2038. 10.1002/1529-0131(199910)42:10<2026::AID-ANR2>3.0.CO;2-J.CrossRefPubMed Sibbitt WL, Sibbitt RR, Brooks WM: Neuroimaging in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum. 1999, 42 (10): 2026-2038. 10.1002/1529-0131(199910)42:10<2026::AID-ANR2>3.0.CO;2-J.CrossRefPubMed
5.
go back to reference Huizinga TW, Steens SC, van Buchem MA: Imaging modalities in central nervous system systemic lupus erythematosus. Curr Opin Rheumatol. 2001, 13 (5): 383-388. 10.1097/00002281-200109000-00007.CrossRefPubMed Huizinga TW, Steens SC, van Buchem MA: Imaging modalities in central nervous system systemic lupus erythematosus. Curr Opin Rheumatol. 2001, 13 (5): 383-388. 10.1097/00002281-200109000-00007.CrossRefPubMed
6.
go back to reference Appenzeller S, Pike GB, Clarke AE: Magnetic resonance imaging in the evaluation of central nervous system manifestations in systemic lupus erythematosus. Clin Rev Allergy Immunol. 2008, 34 (3): 361-366. 10.1007/s12016-007-8060-z.CrossRefPubMed Appenzeller S, Pike GB, Clarke AE: Magnetic resonance imaging in the evaluation of central nervous system manifestations in systemic lupus erythematosus. Clin Rev Allergy Immunol. 2008, 34 (3): 361-366. 10.1007/s12016-007-8060-z.CrossRefPubMed
7.
go back to reference Castellino G, Govoni M, Giacuzzo S, Trotta F: Optimizing clinical monitoring of central nervous system involvement in SLE. Autoimmun Rev. 2008, 7 (4): 297-304. 10.1016/j.autrev.2007.11.022.CrossRefPubMed Castellino G, Govoni M, Giacuzzo S, Trotta F: Optimizing clinical monitoring of central nervous system involvement in SLE. Autoimmun Rev. 2008, 7 (4): 297-304. 10.1016/j.autrev.2007.11.022.CrossRefPubMed
8.
go back to reference Katsumata Y, Harigai M, Kawaguchi Y, Fukasawa C, Soejima M, Takagi K, Tanaka M, Ichida H, Tochimoto A, Kanno T: Diagnostic reliability of cerebral spinal fluid tests for acute confusional state (delirium) in patients with systemic lupus erythematosus: interleukin 6 (IL-6), IL-8, interferon-alpha, IgG index, and Q-albumin. J Rheumatol. 2007, 34 (10): 2010-2017.PubMed Katsumata Y, Harigai M, Kawaguchi Y, Fukasawa C, Soejima M, Takagi K, Tanaka M, Ichida H, Tochimoto A, Kanno T: Diagnostic reliability of cerebral spinal fluid tests for acute confusional state (delirium) in patients with systemic lupus erythematosus: interleukin 6 (IL-6), IL-8, interferon-alpha, IgG index, and Q-albumin. J Rheumatol. 2007, 34 (10): 2010-2017.PubMed
9.
go back to reference Petri M, Naqibuddin M, Carson KA, Wallace DJ, Weisman MH, Holliday SL, Sampedro M, Narayana S, Fox PT, Franklin C: Brain magnetic resonance imaging in newly diagnosed systemic lupus erythematosus. J Rheumatol. 2008, 35 (12): 2348-2354. 10.3899/jrheum.071010.CrossRefPubMed Petri M, Naqibuddin M, Carson KA, Wallace DJ, Weisman MH, Holliday SL, Sampedro M, Narayana S, Fox PT, Franklin C: Brain magnetic resonance imaging in newly diagnosed systemic lupus erythematosus. J Rheumatol. 2008, 35 (12): 2348-2354. 10.3899/jrheum.071010.CrossRefPubMed
10.
go back to reference Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982, 25 (11): 1271-1277. 10.1002/art.1780251101.CrossRefPubMed Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982, 25 (11): 1271-1277. 10.1002/art.1780251101.CrossRefPubMed
11.
go back to reference Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH: Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992, 35 (6): 630-640. 10.1002/art.1780350606.CrossRefPubMed Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH: Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992, 35 (6): 630-640. 10.1002/art.1780350606.CrossRefPubMed
12.
go back to reference Jennings JE, Sundgren PC, Attwood J, McCune J, Maly P: Value of MRI of the brain in patients with systemic lupus erythematosus and neurologic disturbance. Neuroradiology. 2004, 46 (1): 15-21. 10.1007/s00234-003-1049-2.CrossRefPubMed Jennings JE, Sundgren PC, Attwood J, McCune J, Maly P: Value of MRI of the brain in patients with systemic lupus erythematosus and neurologic disturbance. Neuroradiology. 2004, 46 (1): 15-21. 10.1007/s00234-003-1049-2.CrossRefPubMed
13.
go back to reference Kozora E, Thompson LL, West SG, Kotzin BL: Analysis of cognitive and psychological deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum. 1996, 39 (12): 2035-2045. 10.1002/art.1780391213.CrossRefPubMed Kozora E, Thompson LL, West SG, Kotzin BL: Analysis of cognitive and psychological deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum. 1996, 39 (12): 2035-2045. 10.1002/art.1780391213.CrossRefPubMed
14.
go back to reference Neuwelt CM, Lacks S, Kaye BR, Ellman JB, Borenstein DG: Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus. Am J Med. 1995, 98 (1): 32-41. 10.1016/S0002-9343(99)80078-3.CrossRefPubMed Neuwelt CM, Lacks S, Kaye BR, Ellman JB, Borenstein DG: Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus. Am J Med. 1995, 98 (1): 32-41. 10.1016/S0002-9343(99)80078-3.CrossRefPubMed
15.
go back to reference Karassa FB, Ioannidis JP, Boki KA, Touloumi G, Argyropoulou MI, Strigaris KA, Moutsopoulos HM: Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus. Am J Med. 2000, 109 (8): 628-634. 10.1016/S0002-9343(00)00603-3.CrossRefPubMed Karassa FB, Ioannidis JP, Boki KA, Touloumi G, Argyropoulou MI, Strigaris KA, Moutsopoulos HM: Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus. Am J Med. 2000, 109 (8): 628-634. 10.1016/S0002-9343(00)00603-3.CrossRefPubMed
16.
go back to reference American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 1994, American Psychiatric Association, 4 American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 1994, American Psychiatric Association, 4
17.
go back to reference Wechsler D: Wechsler Adult Intelligence Scale - Revised. 1981, New York: The Psychological Corporation Wechsler D: Wechsler Adult Intelligence Scale - Revised. 1981, New York: The Psychological Corporation
18.
go back to reference Lezak MD: Neuropsychological assessment. 1997, New York: Oxford University Press, 3 Lezak MD: Neuropsychological assessment. 1997, New York: Oxford University Press, 3
19.
go back to reference McNair DM, Lorr M, Droppleman LF: Manual for the Profile of Mood States. 1992, San Diego: Educational and Industrial Testing Service McNair DM, Lorr M, Droppleman LF: Manual for the Profile of Mood States. 1992, San Diego: Educational and Industrial Testing Service
20.
go back to reference Merrill JT, Buyon JP: The role of biomarkers in the assessment of lupus. Best Pract Res Clin Rheumatol. 2005, 19 (5): 709-726. 10.1016/j.berh.2005.05.004.CrossRefPubMed Merrill JT, Buyon JP: The role of biomarkers in the assessment of lupus. Best Pract Res Clin Rheumatol. 2005, 19 (5): 709-726. 10.1016/j.berh.2005.05.004.CrossRefPubMed
21.
go back to reference Mills JA: Systemic lupus erythematosus. N Engl J Med. 1994, 330 (26): 1871-1879. 10.1056/NEJM199406303302608.CrossRefPubMed Mills JA: Systemic lupus erythematosus. N Engl J Med. 1994, 330 (26): 1871-1879. 10.1056/NEJM199406303302608.CrossRefPubMed
22.
go back to reference Winfield JB, Brunner CM, Koffler D: Serologic studies in patients with systemic lupus erythematosus and central nervous system dysfunction. Arthritis Rheum. 1978, 21 (3): 289-294. 10.1002/art.1780210301.CrossRefPubMed Winfield JB, Brunner CM, Koffler D: Serologic studies in patients with systemic lupus erythematosus and central nervous system dysfunction. Arthritis Rheum. 1978, 21 (3): 289-294. 10.1002/art.1780210301.CrossRefPubMed
23.
go back to reference Graham JW, Jan W: MRI and the brain in systemic lupus erythematosus. Lupus. 2003, 12 (12): 891-896. 10.1191/0961203303lu498oa.CrossRefPubMed Graham JW, Jan W: MRI and the brain in systemic lupus erythematosus. Lupus. 2003, 12 (12): 891-896. 10.1191/0961203303lu498oa.CrossRefPubMed
24.
go back to reference Sibbitt WL, Sibbitt RR, Griffey RH, Eckel C, Bankhurst AD: Magnetic resonance and computed tomographic imaging in the evaluation of acute neuropsychiatric disease in systemic lupus erythematosus. Ann Rheum Dis. 1989, 48 (12): 1014-1022. 10.1136/ard.48.12.1014.CrossRefPubMedPubMedCentral Sibbitt WL, Sibbitt RR, Griffey RH, Eckel C, Bankhurst AD: Magnetic resonance and computed tomographic imaging in the evaluation of acute neuropsychiatric disease in systemic lupus erythematosus. Ann Rheum Dis. 1989, 48 (12): 1014-1022. 10.1136/ard.48.12.1014.CrossRefPubMedPubMedCentral
25.
go back to reference Sabbadini MG, Manfredi AA, Bozzolo E, Ferrario L, Rugarli C, Scorza R, Origgi L, Vanoli M, Gambini O, Vanzulli L: Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations. Lupus. 1999, 8 (1): 11-19. 10.1191/096120399678847344.CrossRefPubMed Sabbadini MG, Manfredi AA, Bozzolo E, Ferrario L, Rugarli C, Scorza R, Origgi L, Vanoli M, Gambini O, Vanzulli L: Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations. Lupus. 1999, 8 (1): 11-19. 10.1191/096120399678847344.CrossRefPubMed
26.
go back to reference Sanna G, Piga M, Terryberry JW, Peltz MT, Giagheddu S, Satta L, Ahmed A, Cauli A, Montaldo C, Passiu G: Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations. Lupus. 2000, 9 (8): 573-583. 10.1191/096120300678828695.CrossRefPubMed Sanna G, Piga M, Terryberry JW, Peltz MT, Giagheddu S, Satta L, Ahmed A, Cauli A, Montaldo C, Passiu G: Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations. Lupus. 2000, 9 (8): 573-583. 10.1191/096120300678828695.CrossRefPubMed
27.
go back to reference Steens SC, Admiraal-Behloul F, Bosma GP, Steup-Beekman GM, Olofsen H, Le Cessie S, Huizinga TW, Van Buchem MA: Selective gray matter damage in neuropsychiatric lupus. Arthritis Rheum. 2004, 50 (9): 2877-2881. 10.1002/art.20654.CrossRefPubMed Steens SC, Admiraal-Behloul F, Bosma GP, Steup-Beekman GM, Olofsen H, Le Cessie S, Huizinga TW, Van Buchem MA: Selective gray matter damage in neuropsychiatric lupus. Arthritis Rheum. 2004, 50 (9): 2877-2881. 10.1002/art.20654.CrossRefPubMed
Metadata
Title
Diagnostic reliability of magnetic resonance imaging for central nervous system syndromes in systemic lupus erythematosus: a prospective cohort study
Authors
Yasuhiro Katsumata
Masayoshi Harigai
Yasushi Kawaguchi
Chikako Fukasawa
Makoto Soejima
Tokiko Kanno
Katsuji Nishimura
Takayuki Yamada
Hisashi Yamanaka
Masako Hara
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Musculoskeletal Disorders / Issue 1/2010
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/1471-2474-11-13

Other articles of this Issue 1/2010

BMC Musculoskeletal Disorders 1/2010 Go to the issue